Menu

• Ask a Health Expert about APPLICATION SITE EXCORIATION
• Post Your Side Effect related to APPLICATION SITE EXCORIATION
• APPLICATION SITE EXCORIATION and FDA Warnings
• APPLICATION SITE EXCORIATION in Patients Wiki
• Report APPLICATION SITE EXCORIATION in Drug Side Effect Survey

APPLICATION SITE EXCORIATION side effect

What is APPLICATION SITE EXCORIATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Altabax Side Effects Report #5619743-7
Consumer or non-health professional from UNITED STATES reported ALTABAX problem on Dec 17, 2007. Female patient, child 11 years of age, weighting 142.2 lb, was diagnosed with wound infection and was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site excoriation, fungal skin infection, . ALTABAX dosage: unknown. Patient recovered.

Fentanyl Side Effects Report #5627339-6
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Female patient, weighting 150.0 lb, was diagnosed with back pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site excoriation, bipolar disorder, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient recovered.

Daytrana Side Effects Report #5653738-2
Physician from UNITED STATES reported DAYTRANA problem on Nov 19, 2007. Male patient, child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site irritation, application site scab, dermatitis contact, . DAYTRANA dosage: 20 MG, 1X/DAY:QD; 20 MG, 1X/DAY:QD, TRANSDERMAL. Patient recovered.

Duragesic Side Effects Report #5582613-7
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2007. Male patient, weighting 168.0 lb, was diagnosed with pain, breakthrough pain, sleep disorder, depression, prostatic disorder and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, skin cancer, . DURAGESIC dosage: unknown. During the same period patient was treated with CHANTIX, OXYCONTIN, PEROCET, FLEXERIL, TRAZODONE, LEXAPRO, AMBIEN CR, FLOMAX. Patient recovered.


Fentanyl Side Effects Report #5599917-4
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Jan 14, 2008. Female patient, weighting 125.0 lb, was diagnosed with fibromyalgia, depression, blood cholesterol increased, neuralgia and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site pruritus, caesarean section, pre-eclampsia, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, PROZAC, GUAIFENESIN, ZOCOR, LYRICA, AMITRIPTYLINE. Patient recovered.

Duragesic Side Effects Report #5550779-0
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Female patient, weighting 175.0 lb, was diagnosed with pain, muscle spasms, vomiting, nausea, thyroid disorder, mental disorder and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, arthralgia, back disorder, breakthrough pain, depression, fibromyalgia, gastric disorder, . DURAGESIC dosage: unknown. During the same period patient was treated with FLEXERIL, PHENERGAN, COMPAZINE, LEVOTHROID, KLONOPIN. Patient was hospitalized. Patient recovered.

Desoximetasone Side Effects Report #5520946-0
Consumer or non-health professional from UNITED STATES reported DESOXIMETASONE problem on Oct 02, 2007. Female patient, 57 years of age, was diagnosed with eczema and was treated with DESOXIMETASONE. After drug was administered, patient experienced the following problems/side effects: application site excoriation, condition aggravated, eczema, gait disturbance, hyperkeratosis, no therapeutic response, pain in extremity, skin chapped, . DESOXIMETASONE dosage: unknown. During the same period patient was treated with TRILEPTAL, PAXIL, KLONOPIN. Patient recovered.

Duragesic Side Effects Report #5525398-2
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2007. Female patient, weighting 97.00 lb, was diagnosed with pain, neuralgia and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site irritation, breakthrough pain, chronic obstructive pulmonary disease, . DURAGESIC dosage: unknown. During the same period patient was treated with NEURONTIN. Patient recovered.

Chloraprep Side Effects Report #5491792-1
Health Professional from UNITED STATES reported CHLORAPREP problem on Oct 18, 2007. Male patient, weighting 2.91 lb, was diagnosed with central venous catheterisation, removal of inert matter from skin or subcutaneous tissue and was treated with CHLORAPREP. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site pustules, . CHLORAPREP dosage: unknown. Patient recovered.


Abreva Side Effects Report #5462530-3
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Female patient, 35 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site excoriation, . ABREVA dosage: unknown. Patient recovered.

Catapres Side Effects Report #5426801-9
Health Professional from UNITED STATES reported CATAPRES problem on May 22, 2007. Female patient, 83 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site pruritus, erythema, . CATAPRES dosage: unknown. During the same period patient was treated with ALTACE, SULAR, ACTONEL, GLIMEPIRIDE, ZYRTEC, LIPITOR, PAROXETINE. Patient recovered.

Fentanyl Side Effects Report #5773333-4
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2008. Female patient, weighting 206.0 lb, was diagnosed with pain, gastrooesophageal reflux disease, hypertension, nausea, headache, arthritis and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site excoriation, device leakage, feeling abnormal, head discomfort, insomnia, malaise, migraine with aura, nausea, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with DURAGESIC, RANITIDINE, COZAAR, HYDROCHLOROTHIAZIDE, PROMETHAZINE, CELEBREX. Patient recovered.

Duragesic Side Effects Report #5776967-6
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on June 10, 2008. Male patient, weighting 190.0 lb, was diagnosed with back pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, pain, thyroid disorder, . DURAGESIC dosage: unknown. During the same period patient was treated with NADOLOL. Patient recovered.

Duragesic Side Effects Report #5739015-X
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 06, 2008. Male patient, weighting 168.0 lb, was diagnosed with pain, breakthrough pain, sleep disorder, depression, prostatic disorder and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site ulcer, precancerous cells present, skin cancer, . DURAGESIC dosage: unknown. During the same period patient was treated with CHANTIX, OXYCONTIN, PEROCET, FLEXERIL, TRAZODONE, LEXAPRO, AMBIEN CR, FLOMAX. Patient recovered.


Duragesic Side Effects Report #5746609-4
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on May 12, 2008. Female patient, weighting 155.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site infection, application site irritation, application site vesicles, feeling abnormal, spinal fracture, . DURAGESIC dosage: unknown. During the same period patient was treated with OXYCONTIN, VICODIN. Patient was hospitalized. Patient recovered.

Duragesic Side Effects Report #5747313-9
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2008. Male patient, weighting 180.0 lb, was diagnosed with pain, breakthrough pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site excoriation, spinal fusion surgery, therapeutic response decreased, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, ROXYCODONE. Patient was hospitalized. Patient recovered.

Fentanyl Side Effects Report #5690646-5
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Mar 21, 2008. Female patient, weighting 195.0 lb, was diagnosed with back pain, hiatus hernia, multiple allergies and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site pruritus, blood cholesterol increased, constipation, eating disorder, therapeutic response decreased, vitamin d deficiency, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, ZANTAC, VOLTAREN, ALLEGRA D, ASPIRIN, HYDROMORPHONE, PRIMROSE OIL, FEXOFENADINE. Patient recovered.

Nizoral Side Effects Report #5370087-0
NIZORAL A problem was reported by a Physician from UNITED STATES on June 18, 2007. Male patient, weighting 183.0 lb, was diagnosed with dandruff, hypertension, blood cholesterol increased, routine health maintenance, gastrooesophageal reflux disease and was treated with NIZORAL A. After drug was administered, patient experienced the following problems/side effects: application site excoriation, . NIZORAL A dosage: unknown. During the same period patient was treated with NIZORAL A, LASIX, LISINOPRIL, TOPROL, LIPITOR, POTASSIUM ACETATE, PREVACID. Patient recovered.

Nicorette Side Effects Report #5641350-0
Consumer or non-health professional from UNITED STATES reported NICORETTE problem on June 26, 2007. Male patient, 35 years of age, was treated with NICORETTE. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, application site irritation, . NICORETTE dosage: unknown. During the same period patient was treated with NICODERM CQ. Patient recovered.


Nicotine Side Effects Report #5643930-5
NICOTINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2008. Female patient was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site excoriation, application site irritation, confusional state, emotional disorder, hallucination, auditory, hallucination, visual, malaise, staring, . NICOTINE dosage: 21 MG, TRANSDERMAL. Patient recovered.

Fentanyl Side Effects Report #5583799-0
Physician from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Dec 27, 2007. Female patient, weighting 148.0 lb, was diagnosed with neuralgia and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, burning sensation, fatigue, fibromyalgia, inadequate analgesia, rash, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with DURAGESIC, PEPCID, LEXAPRO. Patient recovered.

Duragesic Side Effects Report #5477959-7
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 264.0 lb, was diagnosed with pain, breakthrough pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, incorrect dose administered, right ventricular failure, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, LASIX, BUMEX, NARCO. Patient recovered.

Daytrana Side Effects Report #5494140-6
Consumer or non-health professional from UNITED STATES reported DAYTRANA problem on Oct 12, 2007. Male patient, child 8 years of age, weighting 104.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, application site pruritus, application site vesicles, investigation abnormal, scarlet fever, . DAYTRANA dosage: 20 MG, 1X/DAY: QD,TRANSDERMAL. Patient recovered.

Fentanyl Side Effects Report #5495696-X
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2007. Female patient, weighting 143.0 lb, was diagnosed with neuralgia and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, fatigue, fibromyalgia, inadequate analgesia, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with DURAGESIC, PEPCID, LEXAPRO. Patient recovered.

Duragesic Side Effects Report #5378202-X
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on June 26, 2007. Female patient, weighting 180.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, application site excoriation, application site pruritus, application site urticaria, breakthrough pain, feeling abnormal, hyperhidrosis, lymphadenopathy, . DURAGESIC dosage: unknown. During the same period patient was treated with FLEXERIL. Patient recovered.

Ortho Side Effects Report #5395224-3
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Female patient, 34 years of age, weighting 191.0 lb, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: angina unstable, application site excoriation, application site pruritus, pulmonary embolism, . ORTHO EVRA dosage: unknown. During the same period patient was treated with SYNTHROID. Patient was hospitalized. Patient recovered.

Duragesic Side Effects Report #5378202-X
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on June 26, 2007. Female patient, weighting 180.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, application site excoriation, application site pruritus, application site urticaria, breakthrough pain, feeling abnormal, hyperhidrosis, lymphadenopathy, . DURAGESIC dosage: unknown. During the same period patient was treated with FLEXERIL. Patient recovered.

Ortho Side Effects Report #5395224-3
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Female patient, 34 years of age, weighting 191.0 lb, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: angina unstable, application site excoriation, application site pruritus, pulmonary embolism, . ORTHO EVRA dosage: unknown. During the same period patient was treated with SYNTHROID. Patient was hospitalized. Patient recovered.

Duragesic Side Effects Report #5780178-8
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on June 11, 2008. Female patient, weighting 165.0 lb, was diagnosed with pain, vomiting, nausea and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, application site irritation, breakthrough pain, hypersomnia, lyme disease, nausea, polycystic ovaries, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL, DILAUDID, BENADRYL, PHENERGAN, ZOFRAN. Patient was hospitalized. Patient recovered.

Climara Side Effects Report #5782779-X
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2008. Female patient, 40 years of age, weighting 180.8 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, . CLIMARA dosage: unknown. During the same period patient was treated with PREDNISONE, METHOTREXATE, NEXIUM, VOPARIN NOS, ORENTHIA NOS. Patient recovered.

Equate Side Effects Report #5793273-4
Consumer or non-health professional from UNITED STATES reported EQUATE problem on June 26, 2008. Male patient, 59 years of age, weighting 205.0 lb, was diagnosed with sterilisation and was treated with EQUATE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site excoriation, application site irritation, application site pain, onychomadesis, wound, . EQUATE dosage: unknown. Patient recovered.

Climara Side Effects Report #5698464-9
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, 48 years of age, weighting 163.1 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site excoriation, application site rash, . CLIMARA dosage: unknown. Patient recovered.

Daytrana Side Effects Report #5322044-8
Pharmacist from UNITED STATES reported DAYTRANA problem on May 08, 2007. Male patient, weighting 165.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site excoriation, . DAYTRANA dosage: 10MG QD TRANSDERMAL. Patient recovered.

Nicorette Side Effects Report #5260642-0
NICORETTE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Female patient, 33 years of age, was treated with NICORETTE. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site excoriation, application site pruritus, application site swelling, hypersensitivity, swelling face, swollen tongue, . NICORETTE dosage: unknown. During the same period patient was treated with NICODERM CQ. Patient recovered.

Nicotine Side Effects Report #5552642-8
Physician from UNITED STATES reported NICOTINE problem on Nov 21, 2007. Male patient, 46 years of age, was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site excoriation, application site reaction, application site scar, open wound, scab, skin injury, . NICOTINE dosage: 21 MG, QD, TRANSDERMAL. Patient recovered.

Estrogen Side Effects Report #5330699-7
ESTROGEN NOS problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Female patient, 45 years of age, weighting 140.0 lb, was treated with ESTROGEN NOS. After drug was administered, patient experienced the following problems/side effects: abdominoplasty, application site erythema, application site excoriation, application site vesicles, wound, . ESTROGEN NOS dosage: unknown. During the same period patient was treated with VIVELLE. Patient recovered.